car-t
Latest
FDA halts Juno's gene-altering cancer trials after three deaths
The Food and Drug Administration has temporarily halted a cancer-treating study after three patients died of swelling in the brain. Biopharmaceutical company Juno Therapeutics had been testing an experimental method known as CAR-T to treat tumors, but it's unclear if trials will continue.
